Free Trial

SHL Telemedicine (SHLT) Competitors

SHL Telemedicine logo
$2.85 -0.03 (-1.04%)
As of 01/21/2025 03:57 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

SHLT vs. TOI, CCM, HIMS, TDOC, AUNA, SBC, AIRS, LFMD, CHRS, and INFU

Should you be buying SHL Telemedicine stock or one of its competitors? The main competitors of SHL Telemedicine include Oncology Institute (TOI), Concord Medical Services (CCM), Hims & Hers Health (HIMS), Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), AirSculpt Technologies (AIRS), LifeMD (LFMD), Coherus BioSciences (CHRS), and InfuSystem (INFU).

SHL Telemedicine vs.

Oncology Institute (NASDAQ:TOI) and SHL Telemedicine (NASDAQ:SHLT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, community ranking, institutional ownership, dividends and earnings.

SHL Telemedicine has a net margin of 0.00% compared to Oncology Institute's net margin of -17.63%. SHL Telemedicine's return on equity of 0.00% beat Oncology Institute's return on equity.

Company Net Margins Return on Equity Return on Assets
Oncology Institute-17.63% -186.83% -34.58%
SHL Telemedicine N/A N/A N/A

36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 20.1% of SHL Telemedicine shares are owned by institutional investors. 9.5% of Oncology Institute shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Oncology Institute has a beta of 0.13, indicating that its stock price is 87% less volatile than the S&P 500. Comparatively, SHL Telemedicine has a beta of -0.3, indicating that its stock price is 130% less volatile than the S&P 500.

SHL Telemedicine has lower revenue, but higher earnings than Oncology Institute.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oncology Institute$324.24M0.14-$83.07M-$0.78-0.77
SHL Telemedicine$57.08MN/A-$7.06MN/AN/A

In the previous week, SHL Telemedicine's average media sentiment score of 0.00 beat Oncology Institute's score of -0.36 indicating that SHL Telemedicine is being referred to more favorably in the news media.

Company Overall Sentiment
Oncology Institute Neutral
SHL Telemedicine Neutral

Oncology Institute received 3 more outperform votes than SHL Telemedicine when rated by MarketBeat users. However, 100.00% of users gave SHL Telemedicine an outperform vote while only 66.67% of users gave Oncology Institute an outperform vote.

CompanyUnderperformOutperform
Oncology InstituteOutperform Votes
4
66.67%
Underperform Votes
2
33.33%
SHL TelemedicineOutperform Votes
1
100.00%
Underperform Votes
No Votes

Oncology Institute presently has a consensus price target of $2.50, indicating a potential upside of 317.85%. SHL Telemedicine has a consensus price target of $11.00, indicating a potential upside of 285.96%. Given Oncology Institute's higher probable upside, analysts plainly believe Oncology Institute is more favorable than SHL Telemedicine.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oncology Institute
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
SHL Telemedicine
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Summary

Oncology Institute and SHL Telemedicine tied by winning 6 of the 12 factors compared between the two stocks.

Get SHL Telemedicine News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHLT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHLT vs. The Competition

MetricSHL TelemedicineOffices & clinics of medical doctors IndustryMedical SectorNASDAQ Exchange
Market Cap$42.29M$1.09B$5.39B$9.13B
Dividend YieldN/AN/A5.37%4.00%
P/E RatioN/A13.5089.0817.53
Price / SalesN/A1.731,255.34136.91
Price / Cash66.4938.9136.6032.90
Price / Book0.558.374.964.69
Net Income-$7.06M-$52.07M$117.89M$224.57M
7 Day Performance0.71%8.92%1.72%1.69%
1 Month Performance-5.94%23.12%3.66%5.34%
1 Year Performance-64.15%-7.16%25.79%21.47%

SHL Telemedicine Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHLT
SHL Telemedicine
N/A$2.85
-1.0%
$11.00
+286.0%
-61.4%$42.29M$57.08M0.00583Gap Down
TOI
Oncology Institute
2.495 of 5 stars
$0.31
+3.3%
$2.50
+702.1%
-72.0%$23.55M$324.24M-0.40660News Coverage
Gap Up
CCM
Concord Medical Services
0.818 of 5 stars
$4.51
-2.4%
N/A-51.6%$19.58M$471.70M0.00970Analyst Forecast
Gap Down
HIMS
Hims & Hers Health
3.5563 of 5 stars
$25.83
+1.7%
$25.13
-2.7%
+257.0%$5.64B$1.24B58.711,046Insider Trade
Gap Up
TDOC
Teladoc Health
3.1559 of 5 stars
$9.72
-1.5%
$12.24
+25.9%
-53.1%$1.67B$2.59B-1.685,600
AUNA
Auna
3.8595 of 5 stars
$7.30
+2.7%
$13.40
+83.6%
N/A$539.60M$4.34B0.0014,958Positive News
High Trading Volume
SBC
SBC Medical Group
N/A$5.06
-1.0%
N/AN/A$521.29M$223.34M0.00N/ANews Coverage
AIRS
AirSculpt Technologies
1.0654 of 5 stars
$4.79
-19.9%
$5.50
+14.8%
-31.9%$277.26M$188.78M-34.21240Gap Down
High Trading Volume
LFMD
LifeMD
2.8421 of 5 stars
$4.72
-0.4%
$11.14
+136.1%
-14.1%$204.43M$193.06M-7.38230
CHRS
Coherus BioSciences
3.8234 of 5 stars
$1.47
flat
$5.38
+265.6%
-45.9%$169.36M$304.34M-18.38330Positive News
INFU
InfuSystem
1.5261 of 5 stars
$7.91
+4.9%
$13.00
+64.3%
N/A$168.20M$132.78M131.86410

Related Companies and Tools


This page (NASDAQ:SHLT) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners